| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ironwood Pharmaceuticals Inc (IRWD) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 20 sells. IRWD is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.90M | $6.93M | - | |
| VP | 658.0K | $2.40M | - | |
| Other | 500.5K | $1.83M | - | |
| Other | 416.6K | $1.52M | - | |
| Other | 350.4K | $1.28M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 21, 2019 | McCourt Thomas A66 | Chief Commercial Officer | Sell | 4,841 | $14.31 | $69,275.12 | -0.9% | |
| Jan 25, 2019 | Hecht Peter M | Chief Executive Officer | Sale+OE | 89,551 | $12.53 | $1,122,208.73 | -0.6% | |
| Dec 6, 2018 | McHugh Julie55 | Director | Sell | 1,500 | $12.46 | $18,690.00 | -1.6% | |
| Dec 6, 2018 | Olanoff Lawrence S | Director | Sell | 2,000 | $12.47 | $24,940.00 | -4.8% | |
| Nov 9, 2018 | Consylman Gina | Chief Financial Officer | Sell | 1,358 | $11.81 | $16,037.98 | -1.4% | |
| Oct 5, 2018 | Currie Mark G53 | Chief Scientific Officer | Sale+OE | 233,301 | $17.81 | $4,155,570.17 | -67.5% | |
| Sep 5, 2018 | Olanoff Lawrence S | Director | Sell | 2,000 | $19.10 | $38,200.00 | -4.6% | |
| Sep 5, 2018 | McHugh Julie55 | Director | Sell | 1,500 | $19.10 | $28,650.00 | -1.6% | |
| Aug 24, 2018 | Currie Mark G53 | Chief Scientific Officer | Sale+OE | 65,000 | $18.39 | $1,195,350.00 | -7.7% | |
| Aug 23, 2018 | Currie Mark G53 | Chief Scientific Officer | Sale+OE | 130,000 | $18.45 | $2,398,500.00 | -7.7% |